Home/Filings/4/0000950170-24-075627
4//SEC Filing

Humphrey Jeffrey 4

Accession 0000950170-24-075627

CIK 0001521036other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 4:30 PM ET

Size

6.9 KB

Accession

0000950170-24-075627

Insider Transaction Report

Form 4
Period: 2024-06-17
Humphrey Jeffrey
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-06-17+16,18816,188 total
    Exercise: $82.63Exp: 2034-06-17Common Stock (16,188 underlying)
  • Award

    Common Stock

    2024-06-17$82.63/sh+9,076$749,9509,076 total
Footnotes (2)
  • [F1]Consists of 9,076 restricted stock units that vest in equal installments over a three-year period.
  • [F2]The option vests in three equal annual installments beginning on June 17, 2025.

Documents

1 file

Issuer

Lantheus Holdings, Inc.

CIK 0001521036

Entity typeother

Related Parties

1
  • filerCIK 0001816944

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:30 PM ET
Size
6.9 KB